Introduction
Chronic recurrent mutifocal osteomyelitis (CRMO) (OMIM-number-259680), a rare form of autoinflammatory disease of the bone marrow of unknown aetiology, which takes a sub-acute course. First described in 1972 by Gideon et al, CRMO is primarly a diagnosis of exclusion as suggested by negative bone biopsy for neoplasms and negative bone culture to rule out infectious causes. In our case, we have a case cohort of a female child from 2011 until the present. During each episode of the disease, NSAIDs, empirical antibiotics and a course of steroids were given.
Objectives

Primary objective
To identify the radiographic imaging perspective of the recurrent inflammatory attacks on the bone, considering time period of each attack, a follow up case cohort for five years. 
Secondary objective
Results
The first presentation was at 9 years of age with a clinical lesion on the right 2nd metatarsal. X-ray revealed hypolucent lytic lesion. A bone biopsy for histopathology revealed chronic inflammatory infiltrate with predominant monocytes & lymphocytes suggestive of osteomyelitis, bacteriological culture of the sample was sterile and mycobacterial-RT-PCR was negative.
The second episode was after two weeks at the rightshoulder and X-ray revealed a permeative sclerotic lesion at humerus. PDFS, T1WI and T2WI MRI shows hypointense rim was suggestive of sclerosis with contrast enhancement suggestive of subperiosteal infection. Investigations included negative HLA-B27, negative ANA-profile for screening of autoimmune disorders, negative CRP and ESR showed elevation. Abdominal-ultrasound to rule out IBD and was normal. MRI was taken & provisional diagnosis of CRMO was made based on Iyer et al criteria.
In 2015, recurrence of pain occurred in the right arm. 3-phase-Tc99MDP whole-body-scintigraphy did not show any asymptomatic foci of infection other than the humerus. A follow up MRI showed that the lesion has extended distally towards the diaphysis of humerus 2 Medical College Trivandrum, Department of Pediatrics, Trivandrum, India Full list of author information is available at the end of the article 23cm down towards elbow, when compared to the previous year imaging. EQ5D-5L index value as generic health outcome assessment is 0.722, with Zimbabwe taken arbitarily as standard. (max value is 1 assigned for positive health), EQ-VAS scale coded response value in is 72. (max value for best possible state of health is 100).
Discussion
The radiographic pattern, shows that TIRM, STIR sequence is helpful in assessing marrow edema, diffusion restriction is not seen usually, CT scan aids in assessing cortical thickening of bone and post contrast enhancement of lesion present indicative of a severe disease. A 3-phase-bone-scintigraphy, help to pick asymptomatic sites(sensitivity 73% to 100%) usually shows uptake in all three phases
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